PaxMedica secures immediate exercise of warrants
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 03 2024
0mins
Should l Buy ?
Warrant Exercise Agreement: PaxMedica has entered into agreements for the immediate exercise of warrants to purchase 4,423,080 shares of common stock at a reduced price of $0.20 per share, with an expected closing date around September 4, 2024.
Use of Proceeds: The company anticipates gross proceeds of approximately $884,616 from this exercise, which will be allocated towards the development of PAX-101, working capital, and general corporate purposes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
